Literature DB >> 32942029

New insight into the role of exosomes in vitiligo.

Pui Mun Wong1, Lili Yang1, Lingli Yang2, Huali Wu3, Wen Li1, Xin Ma1, Ichiro Katayama4, Huimin Zhang5.   

Abstract

Exosomes are nanosized extracellular vesicles that originate from endosomes and are secreted by most cells into the extracellular space. They serve as mediators of intercellular communication and have been implicated in the regulation of several physiological and pathological processes. Vitiligo is a depigmentation skin disease caused by progressive destruction of autologous epidermal melanocytes. Autoimmune intolerance is one of the leading theories proposed for melanocyte destruction in vitiligo via CD8+, regulatory T (Treg) and T helper 17 (Th17) cell imbalance in adaptive immunity. In this review, we investigate the association of exosomes with vitiligo and emphasize the role of exosomes in immune regulation, melanocyte-keratinocyte interactions, and melanogenesis. The exosomal pathway is necessary for the regulation of CD8+, Treg and Th17 cells in both pathological and physiological conditions. Exosomes derived under pathological conditions can influence CD8+, Treg and Th17 cell balance in the disease microenvironment, which may contribute to disruption of autoimmune tolerance in vitiligo. In addition, exosomes serve as mediators of communication between keratinocytes and melanocytes in the melanogenesis pathway and may also be involved in melanosome transport. They also regulate melanocyte survival and the protein expression of enzymes such as tyrosinase (TYR), tyrosinase-related protein 1 (TYRP1), tyrosinase-related protein-2 (TYRP2) and microphthalmia-associated transcription factor (MITF) in melanogenesis, which suggests that melanin production is associated with exosomes. An improved understanding of the role of exosomes in immune regulation and melanogenesis may help to elucidate the pathogenesis of vitiligo and lead to the development of potential diagnostic markers and therapeutic options.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Autoimmune response; Exosome; Keratinocytes; Melanocytes; Melanogenesis; Vitiligo

Year:  2020        PMID: 32942029     DOI: 10.1016/j.autrev.2020.102664

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  6 in total

Review 1.  Update on the pathogenesis of vitiligo.

Authors:  Helena Zenedin Marchioro; Caio César Silva de Castro; Vinicius Medeiros Fava; Paula Hitomi Sakiyama; Gerson Dellatorre; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2022-05-25       Impact factor: 2.113

Review 2.  Engineered antigen-specific regulatory T cells for autoimmune skin conditions.

Authors:  Zhussipbek Mukhatayev; Yekaterina O Ostapchuk; Deyu Fang; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2021-01-18       Impact factor: 17.390

Review 3.  Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.

Authors:  Wei-Ling Chang; Woan-Ruoh Lee; Yung-Che Kuo; Yen-Hua Huang
Journal:  Front Cell Dev Biol       Date:  2021-12-14

Review 4.  Current Concepts of Vitiligo Immunopathogenesis.

Authors:  Nika Hlača; Tina Žagar; Marija Kaštelan; Ines Brajac; Larisa Prpić-Massari
Journal:  Biomedicines       Date:  2022-07-08

5.  Differential Expression of Serum Exosomal Hsa-miR-487b-3p in Progressive Vitiligo Before and After Systemic Corticosteroid Treatment.

Authors:  Haixin Luo; Bo Xie; Jinhui Xu; Yuqi Zhu; Jiayi Sun; Yuqing Shen; Xiuzu Song
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-07-18

Review 6.  Harnessing the Therapeutic Potential of Exosomes: A Novel Strategy for Anticancer and Antiviral Therapy.

Authors:  Njinju Asaba Clinton; Nkembi-Leke Joshua Ageboh; Baie Decler Nkache; Ebamu Sylvia Mencha; Asonganyi Aminkeng; Ewalu Justa Ndobegang; Esembieng Mencha Ivo; Simaa Rene Vigha; Cyril Jabea Ekabe
Journal:  Biomed Res Int       Date:  2022-09-12       Impact factor: 3.246

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.